Please login to the form below

Not currently logged in
Email:
Password:

Chimerix

This page shows the latest Chimerix news and features for those working in and with pharma, biotech and healthcare.

Merck says drug for CMV in transplant patients hits targets

Merck says drug for CMV in transplant patients hits targets

The company's good news comes after another CMV drug developer - Chimerix - reported that its brincidofovir CMV candidate failed a pair of pivotal trials.

Latest news

  • Chimerix hit as lead drug brincidofovir flunks trial Chimerix hit as lead drug brincidofovir flunks trial

    Chimerix hit as lead drug brincidofovir flunks trial. Antiviral failed to meet its objectives in late-stage study. ... Both GVHD and use of corticosteroids are risk factors for 'late' CMV infection that occurs after discontinuation of the antiviral,"

  • Merck & Co licenses HIV drugs from Chimerix and Yamasa

    Merck &Co licenses HIV drugs from Chimerix and Yamasa. US pharma company also advances internal HIV pipeline. ... Merck &Co has agreed two separate deals with Chimerix and Yamasa to license investigational treatments for HIV.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2012 Pharma deals during July 2012

    Anti-infective deals. A similar size to the Genmab deal at $168m is the agreement between Chimerix, a US based private company developing antiviral therapies and Merck &Co. ... 178. Chimerix / Merck &Co. Licence. Lipid antiviral conjugate in phase 1 for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Glaxo CEO Ernest Mario to chair Chimerix Former Glaxo CEO Ernest Mario to chair Chimerix

    Former Glaxo CEO Ernest Mario to chair Chimerix. Pharma veteran has previously also served as CEO of Alza and Reliant. ... Dr Mario replaces Dr James Niedel, who will remain as a member of the board at Chimerix.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics